We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$4.29B
AUM Growth
+$1.24B
Cap. Flow
+$869M
Cap. Flow %
20.27%
Top 10 Hldgs %
32.29%
Holding
664
New
267
Increased
41
Reduced
55
Closed
201

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$84.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$79.5M
3
FSLR icon
First Solar
FSLR
+$66.4M
4
TWOU
2U Inc
TWOU
+$48.8M
5
CZR icon
Caesars Entertainment
CZR
+$43.9M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$104M
2
AAL icon
American Airlines Group
AAL
+$103M
3
OKE icon
Oneok
OKE
+$69.6M
4
TME icon
Tencent Music
TME
+$68.1M
5
PCG icon
PG&E
PCG
+$64.9M

Sector Composition

Rank Sector Weight
1 Technology 7.83%
2 Consumer Discretionary 6.31%
3 Healthcare 6.17%
4 Financials 3.16%
5 Consumer Staples 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
426
Freeport-McMoran
FCX
$96.7B
$227K 0.01%
+14,500
New +$209K
DYN icon
427
Dyne Therapeutics
DYN
$4.71B
$222K 0.01%
+11,000
New +$241K
LLY icon
428
CALL
Eli Lilly
LLY
$995B
$222K 0.01%
1,500
-36,000
-96% -$5.57M
PSTX
429
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$222K 0.01%
+25,000
New +$284K
EPRT icon
430
Essential Properties Realty Trust
EPRT
$6.74B
$205K ﹤0.01%
+11,200
New +$190K
HRMY icon
431
Harmony Biosciences
HRMY
$2.06B
$203K ﹤0.01%
+6,000
New +$219K
NCLH icon
432
Norwegian Cruise Line
NCLH
$9.22B
$201K ﹤0.01%
+11,722
New +$186K
CLX icon
433
PUT
Clorox
CLX
$11.9B
$189K ﹤0.01%
900
-6,700
-88% -$1.49M
B
434
CALL
Barrick Mining
B
$64B
$186K ﹤0.01%
+6,600
New +$188K
CSCO icon
435
CALL
Cisco
CSCO
$480B
$177K ﹤0.01%
4,500
– –
PRVL
436
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$175K ﹤0.01%
+17,200
New +$231K
LLY icon
437
Eli Lilly
LLY
$995B
$174K ﹤0.01%
+1,176
New +$182K
EVLO
438
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$173K ﹤0.01%
1,637
-4,613
-74% -$420K
PFE icon
439
CALL
Pfizer
PFE
$145B
$169K ﹤0.01%
4,848
– –
REGN icon
440
PUT
Regeneron Pharmaceuticals
REGN
$78.2B
$168K ﹤0.01%
300
– –
DVN icon
441
Devon Energy
DVN
$50.8B
$152K ﹤0.01%
16,034
+5,034
+46% +$53K
NXPI icon
442
CALL
NXP Semiconductors
NXPI
$59.9B
$137K ﹤0.01%
+1,100
New +$134K
WBA
443
CALL
DELISTED
Walgreens Boots Alliance
WBA
$133K ﹤0.01%
3,700
– –
CCL icon
444
Carnival Corporation Ltd
CCL
$40.5B
$128K ﹤0.01%
8,400
– –
CALC icon
445
CalciMedica
CALC
$11.9M
$127K ﹤0.01%
+714
New +$149K
PVLA
446
Palvella Therapeutics
PVLA
$2.02B
$125K ﹤0.01%
+754
New +$172K
WDC icon
447
CALL
Western Digital
WDC
$189B
$121K ﹤0.01%
4,366
– –
TEVA icon
448
PUT
Teva Pharmaceuticals
TEVA
$40.2B
$107K ﹤0.01%
11,900
– –
PXD
449
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
$103K ﹤0.01%
1,200
– –
VIHAU
450
DELISTED
VPC Impact Acquisition Holdings Unit
VIHAU
$100K ﹤0.01%
+10,000
New +$99.9K
16 17
18
19 20

Similar funds

CIG
CCM Investment Group Northfield, Minnesota $946M AUM
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
SWC
Spectrum Wealth Counsel Indianapolis, Indiana $833M AUM 10.83% 1-Year Est. Return
KTA
Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

CAAS Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, CAAS Capital Management held 664 positions worth $4.29B, up 41% from $3.04B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

CAAS Capital Management deployed $869M of net new capital in Q3 2020, opening 267 new positions and adding to 41 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 239,770 shares worth $80.3M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Match Group, an estimated $50.2M trimmed.

  • CAAS Capital Management's largest Q3 2020 buy was State Street SPDR S&P 500 ETF Trust: 239,770 shares worth $80.3M.
  • CAAS Capital Management added most to Keurig Dr Pepper in Q3 2020, an estimated $84.2M increase.
  • CAAS Capital Management's biggest Q3 2020 reduction was Match Group, cutting an estimated $50.2M.
  • CAAS Capital Management fully exited T-Mobile US in Q3 2020, selling an estimated $104M.
  • CAAS Capital Management's ten largest holdings make up 32% of its $4.29B portfolio in Q3 2020.
  • CAAS Capital Management opened 267 new positions and closed 201 in Q3 2020.
  • CAAS Capital Management's portfolio value rose 41% quarter-over-quarter to $4.29B.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.